540 related articles for article (PubMed ID: 15216470)
1. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants.
Ercan TE; Sonmez C; Vural M; Erginoz E; Torunoğlu MA; Perk Y
Vaccine; 2013 Aug; 31(38):4172-6. PubMed ID: 23845808
[TBL] [Abstract][Full Text] [Related]
4. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.
Heininger U; Riffelmann M; Leineweber B; Wirsing von Koenig CH
Pediatr Infect Dis J; 2009 May; 28(5):443-5. PubMed ID: 19319020
[TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
6. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
Healy CM; Rench MA; Baker CJ
Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
[No Abstract] [Full Text] [Related]
8. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
9. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
10. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
11. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal.
Hughes MM; Englund JA; Edwards K; Yoder S; Tielsch JM; Steinhoff M; Khatry SK; LeClerq SC; Katz J
Vaccine; 2017 Dec; 35(48 Pt B):6766-6773. PubMed ID: 29037576
[TBL] [Abstract][Full Text] [Related]
12. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
Gonik B; Puder KS; Gonik N; Kruger M
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
15. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
16. An improved ELISA system for the measurement of IgG antibodies against pertussis toxin (PT) and filamentous hemagglutinin (FHA) in human sera.
Sato Y; Sato H; Kodama H; Uchimura M; Miwa N; Kobayashi T; Yamamoto E; Fujita I; Kumamoto T
Dev Biol Stand; 1991; 73():167-74. PubMed ID: 1778310
[TBL] [Abstract][Full Text] [Related]
17. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
Marley PB; Wilson JV; Habel H; Blaskett A
Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
[TBL] [Abstract][Full Text] [Related]
18. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.
Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Gonen R; Bamberger E
Vaccine; 2014 Oct; 32(44):5787-93. PubMed ID: 25173476
[TBL] [Abstract][Full Text] [Related]
19. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
20. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.
Meade BD; Lynn F; Reed GF; Mink CM; Romani TA; Deforest A; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):595-600. PubMed ID: 7659484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
